Electrolyte disorders with platinum|based chemotherapy

Electrolyte disorders with platinum-based chemotherapy - PubMed

Platinum chemotherapy, particularly cisplatin, is commonly associated with electrolyte imbalances, including hypomagnesemia, hypokalemia, hypophosphatemia, ...

Electrolyte disorders with platinum-based chemotherapy

Platinum chemotherapy, particularly cisplatin, is commonly associated with electrolyte imbalances, including hypomagnesemia, hypokalemia, ...

Electrolyte Disorders Induced by Antineoplastic Drugs - Frontiers

Platinum-derived agents can induce hypokalemia due to renal K wasting secondary to hypomagnesemia. The incidence of cisplatin-related hypokalemia is around 27% ...

Electrolyte disorders associated with the use of anticancer drugs

Platinum-containing anticancer drugs induce hypomagnesemia, hypokalemia and hypocalcemia. Moreover, platinum-containing drugs are associated with hyponatremia, ...

(PDF) Electrolyte disorders with platinum-based chemotherapy

PDF | Platinum chemotherapy, particularly cisplatin, is commonly associated with electrolyte imbalances, including hypomagnesemia, ...

Electrolyte disorders in cancer patients: a systematic review

Electrolyte disorders are very common complications in cancer patients. They might be associated to a worsening outcome, influencing quality of life, ...

Electrolyte Disorders Associated With Cancer

Patients with malignancies commonly experience abnormalities in serum electrolytes, including hyponatremia, hypokalemia, hyperkalemia, hypophosphatemia, ...

Electrolyte disorders with platinum-based chemotherapy

The objective of this review is to synthesize the literature and summarize the mechanisms responsible for these particular electrolyte disturbances in the ...

Electrolyte disorders with platinum-based chemotherapy

Platinum chemotherapy, particularly cisplatin, is commonly associated with electrolyte imbalances, including hypomagnesemia, hypokalemia, hypophosphatemia, ...

Electrolytes Play a Role in Detecting Cisplatin-Induced Kidney ...

Background and Objective: Cisplatin is a chemotherapy drug used to treat several types of malignancies. It is a platinum-based compound that ...

Frequency of electrolyte imbalance associated with cisplatin in oral ...

Conclusion: Cisplatin-based chemotherapy has a high potential to cause electrolyte imbalance. Most of the abnormalities were of milder nature and not ...

Incidence and spectrum of electrolyte disturbances in cisplatin ...

Conclusions: Cisplatin chemotherapy is associated with hypomagnesaemia in a highly significant percentage of patients. Incidence increases with increase in ...

Serum protein and electrolyte imbalances are associated with ...

Blood samples of cancer patients in study group showed reduction in haemoglobin, neutrophils and platelets. Neutropenic group showed a ...

Electrolyte and acid-base disorders in cancer patients and its impact ...

In conclusion, electrolyte and acid-base disorders are commonly encountered in cancer patients. Patients with comorbidities, renal/liver ...

Electrolyte Imbalance - Chemocare

Certain medications may cause an electrolyte imbalance such as: Chemotherapy drugs (for example, cisplatin); Diuretics (for example, tursemide [Demadex], ...

Potassium imbalances induced by systemic cancer therapy

Platinum-based antineoplastic drugs, namely cisplatin, carboplatin, and oxaliplatin are known to induce several electrolyte disorders including ...

Electrolyte disorders in advanced non-small cell lung cancer ...

Treatment with ICIs in aNSCLC is associated with a significant increased risk of hyponatremia and hypokalemia compared to chemotherapy.

An integrated analysis of hyponatremia in cancer patients receiving ...

Hyponatremia is one of the most common electrolyte abnormalities in cancer patients who receive chemotherapy. However, its actual incidence and risk factors ...

Altmetric – Electrolyte disorders with platinum-based chemotherapy

Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management · Cancer Chemotherapy and Pharmacology, July 2017 · 10.1007/ ...

Electrolyte Disorders as Manifestations of Chemotherapy

R-ICE therapy used to manage Diffuse Large B-Cell. Lymphoma (DLBCL) includes platinum and alkylating agents with known nephrotoxicity. One of.